ATE203668T1 - Verwendung von 11-(3-dimethylaminopropyliden)-6, 11-dihydrodibenz(b,e)oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation - Google Patents
Verwendung von 11-(3-dimethylaminopropyliden)-6, 11-dihydrodibenz(b,e)oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisationInfo
- Publication number
- ATE203668T1 ATE203668T1 AT99928600T AT99928600T ATE203668T1 AT E203668 T1 ATE203668 T1 AT E203668T1 AT 99928600 T AT99928600 T AT 99928600T AT 99928600 T AT99928600 T AT 99928600T AT E203668 T1 ATE203668 T1 AT E203668T1
- Authority
- AT
- Austria
- Prior art keywords
- ovascularization
- dimethylaminopropyliden
- dihydrodibenz
- oxepine
- occular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9276298P | 1998-07-14 | 1998-07-14 | |
PCT/US1999/013275 WO2000003705A1 (en) | 1998-07-14 | 1999-06-15 | Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE203668T1 true ATE203668T1 (de) | 2001-08-15 |
Family
ID=22235027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99928600T ATE203668T1 (de) | 1998-07-14 | 1999-06-15 | Verwendung von 11-(3-dimethylaminopropyliden)-6, 11-dihydrodibenz(b,e)oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1037627B1 (de) |
JP (1) | JP2002520355A (de) |
KR (1) | KR100598723B1 (de) |
CN (1) | CN1114401C (de) |
AR (1) | AR019916A1 (de) |
AT (1) | ATE203668T1 (de) |
AU (1) | AU742237B2 (de) |
BR (1) | BR9906772A (de) |
CA (1) | CA2306393C (de) |
DE (1) | DE69900207T2 (de) |
DK (1) | DK1037627T3 (de) |
ES (1) | ES2159209T3 (de) |
GR (1) | GR3036422T3 (de) |
HK (1) | HK1030362A1 (de) |
PT (1) | PT1037627E (de) |
TW (1) | TW561046B (de) |
WO (1) | WO2000003705A1 (de) |
ZA (1) | ZA200001593B (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU770975B2 (en) | 1999-06-18 | 2004-03-11 | Alcon Laboratories, Inc. | Topical ophthalmic mast cell stabilizers for treating allergic eye diseases |
WO2002034246A2 (en) * | 2000-10-23 | 2002-05-02 | Alcon, Inc. | Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery |
US7112588B2 (en) | 2001-05-21 | 2006-09-26 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
BR0209883A (pt) | 2001-05-21 | 2004-06-08 | Alcon Inc | Uso de inibidores da proteasoma para o tratamento de distúrbios do olho seco |
US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
BR0209965A (pt) * | 2001-05-21 | 2004-04-06 | Alcon Inc | Uso de inibidores de nf-kappab para tratar distúrbios do olho seco |
US6645994B1 (en) | 2001-06-01 | 2003-11-11 | Alcon, Inc. | Method of treating dry eye disorders |
US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
US6825232B2 (en) | 2002-06-14 | 2004-11-30 | Alcon, Inc. | Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
WO2004010894A2 (en) | 2002-07-30 | 2004-02-05 | Omeros Corporation | Ophthalmologic irrigation solutions and method |
MXPA05003063A (es) | 2002-09-20 | 2005-05-27 | Alcon Inc | Uso de inhibidores de la sintesis de citosina para el tratamiento de trastornos de ojos secos. |
WO2004093878A1 (en) * | 2003-04-16 | 2004-11-04 | Alcon, Inc. | Use of fused pyridazine derivatives for treating dry eye disorders |
US20050232972A1 (en) | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
US7923471B2 (en) | 2004-05-14 | 2011-04-12 | Alcon, Inc. | Method of treating dry eye disorders and uveitis |
WO2006014434A2 (en) | 2004-07-02 | 2006-02-09 | Eliot Lazar | Treatment medium delivery device and methods for delivery |
US7223737B1 (en) | 2004-08-13 | 2007-05-29 | Alcon, Inc. | Method of treating dry eye disorders using glycosides |
DK1881823T3 (en) * | 2005-05-17 | 2015-03-02 | Sarcode Bioscience Inc | COMPOSITION AND PROCEDURES FOR TREATMENT OF EYE DISORDERS |
US7745461B1 (en) | 2006-02-27 | 2010-06-29 | Alcon Research, Ltd. | Method of treating dry eye disorders |
KR20140083056A (ko) | 2006-03-17 | 2014-07-03 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물 |
CN103393496B (zh) | 2006-03-31 | 2016-08-17 | 玛提治疗有限公司 | 用于药物治疗的鼻泪引流系统植入物 |
WO2009035571A2 (en) | 2007-09-07 | 2009-03-19 | Qlt Plug Delivery, Inc | Lacrimal implant detection |
US8207226B1 (en) | 2008-06-03 | 2012-06-26 | Alcon Research, Ltd. | Use of FAAH antagonists for treating dry eye and ocular pain |
JP2013510095A (ja) | 2009-11-06 | 2013-03-21 | アルコン リサーチ, リミテッド | ドライアイの軽減のための栄養サプリメント |
AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
TWI705812B (zh) | 2014-12-01 | 2020-10-01 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
CN109311976A (zh) | 2016-06-20 | 2019-02-05 | 诺华股份有限公司 | 使用TNFα拮抗剂治疗干眼症的方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6310784A (ja) * | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
JPH02138215A (ja) * | 1988-08-05 | 1990-05-28 | Dai Ichi Seiyaku Co Ltd | 抗アレルギー・抗炎症剤 |
IE920499A1 (en) * | 1991-02-21 | 1992-08-26 | Merck Frosst Canada Inc | Quinoline-containing ketoacids as leukotriene antagonists |
ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
JP3453152B2 (ja) * | 1992-04-06 | 2003-10-06 | 格 冨山 | 抗炎症点眼剤 |
FR2701948B1 (fr) * | 1993-02-22 | 1996-07-26 | Exsymol Sa | Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires. |
ATE241359T1 (de) * | 1993-03-26 | 2003-06-15 | Beth Israel Hospital | Topische und systemische anwendung von buspiron und seinen derivaten zur behandlung von pathologischen zuständen, die mit immunantworten verbunden sind |
FR2711990B1 (fr) * | 1993-11-05 | 1995-12-08 | Exsymol Sa | Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires. |
JP2852607B2 (ja) * | 1994-06-10 | 1999-02-03 | 雪印乳業株式会社 | ドライアイ治療剤 |
US5641805A (en) * | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
JPH1067684A (ja) * | 1996-06-17 | 1998-03-10 | Mitsubishi Chem Corp | 涙液分泌促進剤 |
WO1998022130A1 (en) * | 1996-11-19 | 1998-05-28 | The Schepens Eye Research Institute, Inc. | Local use of il-1ra in corneal transplant rejection or disorders of the eye |
-
1999
- 1999-06-15 BR BR9906772-2A patent/BR9906772A/pt not_active Application Discontinuation
- 1999-06-15 ES ES99928600T patent/ES2159209T3/es not_active Expired - Lifetime
- 1999-06-15 JP JP2000559840A patent/JP2002520355A/ja not_active Withdrawn
- 1999-06-15 EP EP99928600A patent/EP1037627B1/de not_active Expired - Lifetime
- 1999-06-15 AU AU45634/99A patent/AU742237B2/en not_active Ceased
- 1999-06-15 WO PCT/US1999/013275 patent/WO2000003705A1/en active IP Right Grant
- 1999-06-15 AT AT99928600T patent/ATE203668T1/de active
- 1999-06-15 DK DK99928600T patent/DK1037627T3/da active
- 1999-06-15 CN CN99801501A patent/CN1114401C/zh not_active Expired - Fee Related
- 1999-06-15 PT PT81300632T patent/PT1037627E/pt unknown
- 1999-06-15 CA CA002306393A patent/CA2306393C/en not_active Expired - Fee Related
- 1999-06-15 DE DE69900207T patent/DE69900207T2/de not_active Expired - Lifetime
- 1999-06-15 KR KR1020007004037A patent/KR100598723B1/ko not_active IP Right Cessation
- 1999-06-25 TW TW088110742A patent/TW561046B/zh not_active IP Right Cessation
- 1999-07-13 AR ARP990103415A patent/AR019916A1/es unknown
-
2000
- 2000-03-29 ZA ZA200001593A patent/ZA200001593B/xx unknown
-
2001
- 2001-02-14 HK HK01101081A patent/HK1030362A1/xx not_active IP Right Cessation
- 2001-08-20 GR GR20010401273T patent/GR3036422T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1037627B1 (de) | 2001-08-01 |
PT1037627E (pt) | 2001-11-30 |
CA2306393A1 (en) | 2000-01-27 |
DE69900207D1 (de) | 2001-09-06 |
KR100598723B1 (ko) | 2006-07-11 |
AR019916A1 (es) | 2002-03-27 |
BR9906772A (pt) | 2000-09-26 |
KR20010024508A (ko) | 2001-03-26 |
AU4563499A (en) | 2000-02-07 |
EP1037627A1 (de) | 2000-09-27 |
CA2306393C (en) | 2008-12-23 |
JP2002520355A (ja) | 2002-07-09 |
CN1114401C (zh) | 2003-07-16 |
CN1275078A (zh) | 2000-11-29 |
ES2159209T3 (es) | 2001-09-16 |
HK1030362A1 (en) | 2001-05-04 |
ZA200001593B (en) | 2000-10-25 |
AU742237B2 (en) | 2001-12-20 |
GR3036422T3 (en) | 2001-11-30 |
DK1037627T3 (da) | 2001-10-01 |
TW561046B (en) | 2003-11-11 |
WO2000003705A1 (en) | 2000-01-27 |
DE69900207T2 (de) | 2001-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE203668T1 (de) | Verwendung von 11-(3-dimethylaminopropyliden)-6, 11-dihydrodibenz(b,e)oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation | |
CA2183655A1 (en) | 4-polycyclic amino-substituted quinazoline derivatives | |
CA2216796A1 (en) | Quinazoline derivatives | |
NO970517D0 (no) | Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer | |
EA200300671A1 (ru) | Производные хиназолина, содержащие эти соединения лекарственные средства, их применение и способ их получения | |
DE69601345T2 (de) | Propiophenon-Derivate und Verfahren zur ihrer Herstellung | |
EE200100495A (et) | Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim | |
DE69310065T2 (de) | Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose | |
ATE122031T1 (de) | Aryloxyphenylpropylamine, ihre herstellung und verwendung. | |
ATE335487T1 (de) | Verwendung von pyridazino 4,5-(b)ö-indole-1- acetamide derivaten zur herstellung eines arzneimittels zur behandlung von durch periphere benzodiazepinrezeptoren-störungen verursachte krankheiten | |
DE69808440T2 (de) | Verwendung von (+)mefloquine zur behandlung von malaria | |
DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
ATE147626T1 (de) | Verwendung von pirenzepine, telenzepine oder o- methoxy -sila-hexocyclium zur herstellung eines medikaments zur behandlung und regulierung der augenentwicklung | |
DE60230629D1 (de) | Verwendung von 2,5-dihydroxybenzolsulfonsäure-derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion | |
DE59506374D1 (de) | Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel | |
ATE253905T1 (de) | Verwendung von beta-rezeptorenblocker zur herstellung eines medikaments zur behandlung von krankheiten der äusseren retina | |
CA2260863A1 (en) | Treatment of psychotic disorders | |
IT1276462B1 (it) | Diamidi aromatiche acide ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico | |
DE69610045T2 (de) | Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen | |
ATE247963T1 (de) | Medikament zur behandlung von glaukoma und ischämischer retinopathie | |
ATE129244T1 (de) | 4-((thiophen-2-carbonyl)oxy>pyrrolidin-2- carbonsäure, deren herstellung und deren verwendung als entzündungshemmendes und wundheilendes mittel. | |
DE69412794T2 (de) | 2'-desoxy-5-fluoruridin, pharmazeutisch anwendbare salze davon, verfahren zu ihrer herstellung und antitumormedikament | |
RU94016913A (ru) | Способ хирургической коррекции остаточной миопии после кератотомии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner |